рус eng 中文 عربي esp por fra tgl
рус eng 中文 عربي esp por fra tgl

Press Releases

Press Releases

RDIF, the Moscow Government and the Gamaleya National Research Center of Epidemiology and Microbiology announce the start of a post-registration clinical trial of a vaccine against coronavirus

Press release, 26.08.2020

RDIF and SK-Pharmacy agree to supply Sputnik V vaccine to Kazakhstan

Press release, 26.08.2020

Details about the advantages of the human adenoviral vector vaccines are published on the “Sputnik V” website

Press release, 20.08.2020

RDIF and Brazil’s Parana state to partner to promote the world's first registered vaccine against coronavirus "Sputnik V"

Press release, 12.08.2020

The RDIF and Gamaleya National Research Institute of Epidemiology and Microbiology website on the “Sputnik V” vaccine was visited from 188 countries in its first 24 hours

Press release, 12.08.2020

RDIF and Gamaleya National Research Institute of Epidemiology and Microbiology launch the first information website on Russian vaccine against coronavirus

Press release, 11.08.2020

RDIF and R-Pharm Group join forces to fight coronavirus and produce Russia’s first vaccine

Press release, 10.06.2020

RDIF, Sistema and the Gamaleya National Research Institute of Epidemiology and Microbiology agree on production of Russia's first coronavirus vaccine

Press release, 10.06.2020

Message has been successfully sent!